2-methoxyestradiol has been researched along with Carcinoma, Renal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnott, J; Bruce, JY; Carducci, M; Eickhoff, J; Liu, G; Logan, T; Pili, R; Treston, A; Wilding, G | 1 |
1 trial(s) available for 2-methoxyestradiol and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate.
Topics: 2-Methoxyestradiol; Administration, Oral; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colloids; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Estradiol; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Nanoparticles; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sunitinib; Survival Analysis; Treatment Failure; United States | 2012 |